
Sign up to save your podcasts
Or


Nicolas shares how Cure51 collaborates with over 100 hospitals worldwide to identify so-called “Exceptional Survivors,” analyze their data, and use AI to find new therapeutic targets for cancers with very low survival rates. A powerful conversation about the future of oncology, the role of data in medicine – and how science and hope go hand in hand.
📌 This episode is in English.
Learn more about our podcast, all episodes, and your hosts – Inga Bergen & Larissa Middendorf – at:
🌐 www.visionaries-health.com
🎧 You’ll also find more inspiring conversations in our German podcast “Visionäre der Gesundheit”, available on all major podcast platforms.
📬 Want to suggest a topic or send us feedback?
Reach out anytime at: [email protected]
By Inga Bergen & Larissa Middendorf (VdG Media)Nicolas shares how Cure51 collaborates with over 100 hospitals worldwide to identify so-called “Exceptional Survivors,” analyze their data, and use AI to find new therapeutic targets for cancers with very low survival rates. A powerful conversation about the future of oncology, the role of data in medicine – and how science and hope go hand in hand.
📌 This episode is in English.
Learn more about our podcast, all episodes, and your hosts – Inga Bergen & Larissa Middendorf – at:
🌐 www.visionaries-health.com
🎧 You’ll also find more inspiring conversations in our German podcast “Visionäre der Gesundheit”, available on all major podcast platforms.
📬 Want to suggest a topic or send us feedback?
Reach out anytime at: [email protected]